Collectively, the anti-inflammatory effects of cilastatin reduced the hyperinflammatory state associated with sepsis, leading to decreased expression of endothelial adhesion molecules (VCAM-1, ICAM-1), reduced chemokine production, and lowered leukocyte infiltration in the kidney. The gene discussed is ICAM1; the disease is Sepsis.